China 2024 Outlook: Biotech To Feel Ongoing Chill Despite Dealmaking Cheer

Innovative Funding Methods Being Pursued

Biotech founders and executives in China are having to embrace continuing uncertainty around funding as the light at the end of the tunnel still appears a way off, but partnerships and alternative financing routes are providing some relief. 

China Flag with numbers
outlook for China biotech set to remain challenging in 2024 • Source: Shutterstock

Many Chinese biotech executives are preparing for the worst and say the dark days in the sector are not yet numbered.

Beijing-based neuroscience startup InfiBrain Tech was founded in January 2021 and received tens of millions of dollars in pre-A round...

More from China

More from Focus On Asia